1531 - 1540 of 9134 Results
Title
Year
- Fecal tyrosine decarboxylase and motor response complications in Parkinson's disease2025RESTRICTEDTitle: Fecal tyrosine decarboxylase and motor response complications in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 138Issue #:Start Page: 107947End Page: 107947Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107947Citation Count: 2
-
RESTRICTEDTitle: Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)Journal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1192End Page: 1200Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00035Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00035Citation Count: 46
-
OPENTitle: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neuronsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 1020End Page: 1048Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2021.1967615Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1967615?needAccess=trueCitation Count: 71
-
OPENTitle: Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 854End Page: 865Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29349Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29349Citation Count: 19
-
OPENTitle: Bioenergetic and protein processing imbalances in iPSC-dopamine neurons from individuals with idiopathic Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 218Issue #:Start Page: 107222End Page: 107222Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107222Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107222Citation Count: 0
- Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson disease2023OPENTitle: Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 9Issue #:Start Page: 100199End Page: 100199Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100199Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100199Citation Count: 6
- Fall risk is associated with amplified functional connectivity of the central executive network in patients with Parkinson’s disease2015RESTRICTEDTitle: Fall risk is associated with amplified functional connectivity of the central executive network in patients with Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 262Issue #: 11Start Page: 2448End Page: 2456Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-015-7865-6Citation Count: 31
-
OPENTitle: Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficitsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 74Issue #:Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.016Best OA location URL: http://doi.org/10.1016/j.nbd.2014.10.016Citation Count: 160
- High priority publications on Parkinson's disease in 20172017RESTRICTEDTitle: High priority publications on Parkinson's disease in 2017Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 1Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30416-7Citation Count: 0
- Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?2020RESTRICTEDTitle: Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 330Issue #:Start Page: 113357End Page: 113357Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2020.113357Citation Count: 21